WINTON GROUP Ltd Lowers Stock Position in Core Laboratories (NYSE:CLB)

WINTON GROUP Ltd lessened its stake in shares of Core Laboratories (NYSE:CLBGet Rating) by 15.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,755 shares of the oil and gas company’s stock after selling 3,297 shares during the quarter. WINTON GROUP Ltd’s holdings in Core Laboratories were worth $352,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of CLB. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Core Laboratories by 103.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,537 shares of the oil and gas company’s stock valued at $30,000 after purchasing an additional 780 shares during the period. Captrust Financial Advisors boosted its stake in shares of Core Laboratories by 185.7% in the first quarter. Captrust Financial Advisors now owns 1,903 shares of the oil and gas company’s stock valued at $60,000 after purchasing an additional 1,237 shares during the period. Whittier Trust Co. boosted its stake in shares of Core Laboratories by 47.3% in the second quarter. Whittier Trust Co. now owns 4,436 shares of the oil and gas company’s stock valued at $88,000 after purchasing an additional 1,425 shares during the period. US Bancorp DE boosted its stake in shares of Core Laboratories by 42.4% in the second quarter. US Bancorp DE now owns 8,467 shares of the oil and gas company’s stock valued at $169,000 after purchasing an additional 2,522 shares during the period. Finally, FORA Capital LLC purchased a new position in shares of Core Laboratories in the first quarter valued at approximately $200,000. Hedge funds and other institutional investors own 98.22% of the company’s stock.

Core Laboratories Stock Down 3.2 %

CLB stock opened at $21.77 on Friday. The company has a current ratio of 2.23, a quick ratio of 1.61 and a debt-to-equity ratio of 1.00. Core Laboratories has a twelve month low of $13.19 and a twelve month high of $35.83. The company’s 50 day moving average is $18.00 and its two-hundred day moving average is $19.65. The stock has a market cap of $1.01 billion, a P/E ratio of 65.97, a PEG ratio of 1.28 and a beta of 2.63.

Core Laboratories Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 28th. Shareholders of record on Monday, November 7th will be issued a dividend of $0.01 per share. The ex-dividend date is Friday, November 4th. This represents a $0.04 dividend on an annualized basis and a yield of 0.18%. Core Laboratories’s payout ratio is currently 12.12%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CLB. StockNews.com began coverage on shares of Core Laboratories in a research note on Wednesday, October 12th. They issued a “hold” rating for the company. Morgan Stanley cut shares of Core Laboratories from an “equal weight” rating to an “underweight” rating and set a $20.00 target price on the stock. in a report on Monday, September 26th. Citigroup raised shares of Core Laboratories from a “sell” rating to a “neutral” rating and reduced their target price for the company from $24.00 to $17.00 in a report on Thursday, October 6th. Finally, Stifel Nicolaus reduced their target price on shares of Core Laboratories from $26.00 to $20.00 in a report on Tuesday, July 26th.

Core Laboratories Profile

(Get Rating)

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.

Further Reading

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories (NYSE:CLBGet Rating).

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.